• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email
    SC 13G/A 1 tv01448-mettlertoledointerna.htm SCHEDULE 13G/A mettlertoledointernationalinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 11)*

    Name of issuer:  Mettler-Toledo International Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  592688105

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  592688105

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    28,844

    7.  SOLE DISPOSITIVE POWER

    2,419,843

    8.  SHARED DISPOSITIVE POWER

    93,209

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,513,052

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.59%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Mettler-Toledo International Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    1900 Polaris Parkway
    Columbus, OH 43240

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    592688105

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $MTD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    8/28/2024$1400.00Equal Weight
    Wells Fargo
    6/3/2024$1250.00Underperform
    Jefferies
    More analyst ratings

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 12% compared with the prior year. Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer deman

      2/6/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,100.00

      5/5/25 8:26:45 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Citigroup with a new price target

      Citigroup upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,400.00

      4/7/25 8:41:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Graham-Bryce Susan claimed ownership of 338 shares (SEC Form 3)

      3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      4/3/25 2:56:39 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Human Resources Magloth Christian exercised 790 shares at a strike of $397.95 and sold $1,037,815 worth of shares (790 units at $1,313.69) (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      2/26/25 12:41:20 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc sold $1,182,719 worth of shares (888 units at $1,331.89), closing all direct ownership in the company (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      2/13/25 11:09:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    SEC Filings

    See more
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/6/25 11:25:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 10-Q filed by Mettler-Toledo International Inc.

      10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/2/25 11:01:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/1/25 5:02:22 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials